rs869312740
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_032608.7(MYO18B):c.6496G>T(p.Glu2166*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
MYO18B
NM_032608.7 stop_gained
NM_032608.7 stop_gained
Scores
2
1
4
Clinical Significance
Conservation
PhyloP100: 1.30
Genes affected
MYO18B (HGNC:18150): (myosin XVIIIB) The protein encoded by this gene may regulate muscle-specific genes when in the nucleus and may influence intracellular trafficking when in the cytoplasm. The encoded protein functions as a homodimer and may interact with F actin. Mutations in this gene are associated with lung cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-26026470-G-T is Pathogenic according to our data. Variant chr22-26026470-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 224413.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO18B | NM_032608.7 | c.6496G>T | p.Glu2166* | stop_gained | 43/44 | ENST00000335473.12 | NP_115997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO18B | ENST00000335473.12 | c.6496G>T | p.Glu2166* | stop_gained | 43/44 | 1 | NM_032608.7 | ENSP00000334563.8 | ||
MYO18B | ENST00000407587.6 | c.6499G>T | p.Glu2167* | stop_gained | 43/44 | 1 | ENSP00000386096.2 | |||
MYO18B | ENST00000536101.5 | c.6496G>T | p.Glu2166* | stop_gained | 43/43 | 1 | ENSP00000441229.1 | |||
MYO18B | ENST00000539302.5 | n.*3954G>T | non_coding_transcript_exon_variant | 41/42 | 1 | ENSP00000437587.1 | ||||
MYO18B | ENST00000539302.5 | n.*3954G>T | 3_prime_UTR_variant | 41/42 | 1 | ENSP00000437587.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2015 | - - |
Nemaline myopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Muscle and Diseases Team, Institut de Génétique et Biologie Moléculaire et Cellulaire | Mar 01, 2024 | PVS1+PS3+PM1+PM2+PP3+PP4+PP5 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at